BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6539812)

  • 21. [Antiemetic efficacy of betamethasone versus betamethasone combined with metoclopramide in cisplatin-treated cancer patients].
    Kagami Y; Nishio M; Narimatsu N; Tomita M; Sakurai T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):807-10. PubMed ID: 2712578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy.
    Bonneterre J; Chevallier B; Metz R; Fargeot P; Pujade-Lauraine E; Spielmann M; Tubiana-Hulin M; Paes D; Bons J
    J Clin Oncol; 1990 Jun; 8(6):1063-9. PubMed ID: 2140854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind crossover trial of droperidol, metoclopramide, and prochlorperazine as antiemetics in cisplatin therapy.
    Lewis GO; Bernath AM; Ellison NM; Gallagher JG; Porter PA; Rine KT
    Clin Pharm; 1984; 3(6):618-21. PubMed ID: 6391784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of antiemetic effect of high-dose metoclopramide.
    Roemeling RV; Christiansen NP; Hrushesky WJ
    J Clin Oncol; 1985 Sep; 3(9):1273-6. PubMed ID: 4040959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of four antiemetic regimens for the treatment of cisplatin-induced vomiting.
    Póka R; Hernádi Z; Juhász B; Lampé L
    Int J Gynaecol Obstet; 1993 Jul; 42(1):19-24. PubMed ID: 8103470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose dexamethasone and high-dose metoclopramide versus high-dose dexamethasone and sulpiride in the management of cisplatin-induced emesis.
    Rosenblatt E; Lev LM; Robinson E
    Oncology; 1988; 45(4):297-9. PubMed ID: 3387033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the antiemetic efficacy of prochlorperazine and metoclopramide for the treatment of cisplatin-induced emesis: a prospective, randomized, double-blind study.
    Carr BI; Bertrand M; Browning S; Doroshow JH; Presant C; Pulone B; Hill LR
    J Clin Oncol; 1985 Aug; 3(8):1127-32. PubMed ID: 4040552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
    Numbenjapon T; Sriswasdi C; Mongkonsritragoon W; Leelasiri A; Prayoonwiwat W
    J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiemetic effect of oral versus intravenous metoclopramide in patients receiving cisplatin: a randomized, double-blind trial.
    Anthony LB; Krozely MG; Woodward NJ; Hainsworth JD; Hande KR; Brenner DE; Greco FA; Burish TG
    J Clin Oncol; 1986 Jan; 4(1):98-103. PubMed ID: 3510285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiemetic efficacy of high-dose corticosteroids and droperidol in cisplatin-induced emesis: a controlled trial with droperidol and metoclopramide.
    Donovitz GS; O'Quinn AG; Smith ML
    Gynecol Oncol; 1984 Jul; 18(3):320-5. PubMed ID: 6540222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized trial of high dose bolus metoclopramide versus low-dose continuous infusion metoclopramide in the prevention of cisplatin-induced emesis.
    Dana BW; McDermott M; Everts E; Abdulhay G
    Am J Clin Oncol; 1987 Jun; 10(3):253-6. PubMed ID: 3296733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiemetic activity of high doses of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research.
    Roila F; Tonato M; Basurto C; Bella M; Passalacqua R; Morsia D; DiCostanzo F; Donati D; Ballatori E; Tognoni G
    J Clin Oncol; 1987 Jan; 5(1):141-9. PubMed ID: 3543234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiemetic activity of two different high doses of metoclopramide in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research.
    Roila F; Tonato M; Basurto C; Canaletti R; Morsia D; Passalacqua R; DiCostanzo F; Donati D; Colombo N; Ballatori E
    Cancer Treat Rep; 1985 Dec; 69(12):1353-7. PubMed ID: 3907824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevention of nausea and emesis during cytostatic therapy. Antiemetic efficacy of high-dosage oral metoclopramide without and with prednisone].
    Senn HJ; Köhler M; Glaus A; Bachmann-Mettler I; Weigand W
    Dtsch Med Wochenschr; 1986 Jan; 111(4):129-35. PubMed ID: 3510848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research.
    J Clin Oncol; 1997 Jan; 15(1):124-30. PubMed ID: 8996133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind, randomized crossover study of metoclopramide and batanopride for prevention of cisplatin-induced emesis.
    Fleming GF; Vokes EE; McEvilly JM; Janisch L; Francher D; Smaldone L
    Cancer Chemother Pharmacol; 1991; 28(3):226-7. PubMed ID: 1855280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high dose metoclopramide in emesis induced by cisplatin.
    Warrington PS; Allan SG; Cornbleet MA; MacPherson JS; Smyth JF; Leonard RC
    Br Med J (Clin Res Ed); 1986 Nov; 293(6558):1334-7. PubMed ID: 3790968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Difference in persistence of efficacy of two antiemetic regimens on acute emesis during cisplatin chemotherapy. The Italian Group for Antiemetic Research.
    J Clin Oncol; 1993 Dec; 11(12):2396-404. PubMed ID: 8246029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antiemetic effects of combinations of metoclopramide, droperidol and dexamethasone for the prevention of cisplatin-induced gastro-intestinal toxicity: a randomized crossover trial].
    Fujii M; Kiura K; Kamei H; Okabe K; Toki H
    Gan To Kagaku Ryoho; 1987 Jul; 14(7):2257-61. PubMed ID: 3300561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immediate termination of intractable vomiting induced by cisplatin combination chemotherapy using an intensive five-drug antiemetic regimen.
    Plezia PM; Alberts DS; Kessler J; Aapro MS; Graham V; Surwit EA
    Cancer Treat Rep; 1984 Dec; 68(12):1493-5. PubMed ID: 6542448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.